Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Frassoni

Showing results (171-180 of 215) with videos related to

Pageof 22
Sort By:
Bone Marrow Transplantation|April 5, 2011
In vivo B-cell depletion with rituximab for alternative donor hemopoietic SCTA Dominietto, E Tedone, M Soracco, et al.
British Journal of Haematology|February 13, 2001
Is there a graft-versus-leukaemia effect in the absence of graft-versus-host disease in patients undergoing bone marrow transplantation for acute leukaemia?O Ringdén, M Labopin, N C Gorin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2001
Second allogeneic bone marrow transplantation in acute leukemia: results of a survey by the European Cooperative Group for Blood and Marrow TransplantationA Bosi, D Laszlo, M Labopin, et al.
Bone Marrow Transplantation|July 3, 2003
A revised day +7 predictive score for transplant-related mortality: serum cholinesterase, total protein, blood urea nitrogen, gamma glutamyl transferase, donor type and cell doseM P Sormani, R Oneto, B Bruno, et al.
Bone Marrow Transplantation|January 10, 2002
Serum cholinesterase is an early and sensitive marker of graft-versus host-disease (GVHD) and transplant-related mortality (TRM)A Bacigalupo, R Oneto, B Bruno, et al.
Bone Marrow Transplantation|January 1, 1996
Results of allogeneic bone marrow transplantation for acute leukemia have improved in Europe with time--a report of the acute leukemia working party of the European group for blood and marrow transplantation (EBMT)F Frassoni, M Labopin, E Gluckman, et al.
Bone Marrow Transplantation|October 2, 2007
Thiotepa-based reduced intensity conditioning regimen: a 10 year follow upA Bacigalupo, A M Raiola, T Lamparelli, et al.
Bone Marrow Transplantation|January 23, 2002
Pre-emptive therapy of acute graft-versus-host disease: a pilot study with antithymocyte globulin (ATG)A Bacigalupo, R Oneto, T Lamparelli, et al.
Haematologica|June 22, 2001
Conventional hematopoietic stem cell transplants from identical or alternative donors are feasible in recipients relapsing after an autograftC di Grazia, A M Raiola, M T Van Lint, et al.
British Journal of Haematology|September 21, 2000
Quality of life in 244 recipients of allogeneic bone marrow transplantationS Chiodi, S Spinelli, G Ravera, et al.
Pageof 22

Showing results (171-180 of 215) with videos related to

Sort By:
Pageof 22
Bone Marrow Transplantation|April 5, 2011
In vivo B-cell depletion with rituximab for alternative donor hemopoietic SCTA Dominietto, E Tedone, M Soracco, et al.
British Journal of Haematology|February 13, 2001
Is there a graft-versus-leukaemia effect in the absence of graft-versus-host disease in patients undergoing bone marrow transplantation for acute leukaemia?O Ringdén, M Labopin, N C Gorin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 16, 2001
Second allogeneic bone marrow transplantation in acute leukemia: results of a survey by the European Cooperative Group for Blood and Marrow TransplantationA Bosi, D Laszlo, M Labopin, et al.
Bone Marrow Transplantation|July 3, 2003
A revised day +7 predictive score for transplant-related mortality: serum cholinesterase, total protein, blood urea nitrogen, gamma glutamyl transferase, donor type and cell doseM P Sormani, R Oneto, B Bruno, et al.
Bone Marrow Transplantation|January 10, 2002
Serum cholinesterase is an early and sensitive marker of graft-versus host-disease (GVHD) and transplant-related mortality (TRM)A Bacigalupo, R Oneto, B Bruno, et al.
Bone Marrow Transplantation|January 1, 1996
Results of allogeneic bone marrow transplantation for acute leukemia have improved in Europe with time--a report of the acute leukemia working party of the European group for blood and marrow transplantation (EBMT)F Frassoni, M Labopin, E Gluckman, et al.
Bone Marrow Transplantation|October 2, 2007
Thiotepa-based reduced intensity conditioning regimen: a 10 year follow upA Bacigalupo, A M Raiola, T Lamparelli, et al.
Bone Marrow Transplantation|January 23, 2002
Pre-emptive therapy of acute graft-versus-host disease: a pilot study with antithymocyte globulin (ATG)A Bacigalupo, R Oneto, T Lamparelli, et al.
Haematologica|June 22, 2001
Conventional hematopoietic stem cell transplants from identical or alternative donors are feasible in recipients relapsing after an autograftC di Grazia, A M Raiola, M T Van Lint, et al.
British Journal of Haematology|September 21, 2000
Quality of life in 244 recipients of allogeneic bone marrow transplantationS Chiodi, S Spinelli, G Ravera, et al.
Pageof 22